Sun Pharma surges on looking to expand specialty business across different regions

28 Sep 2020 Evaluate

Sun Pharmaceutical Industries is currently trading at Rs. 498.35, up by 8.90 points or 1.82% from its previous closing of Rs. 489.45 on the BSE.

The scrip opened at Rs. 494.25 and has touched a high and low of Rs. 498.35 and Rs. 492.45 respectively. So far 19073 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 564.90 on 28-Aug-2020 and a 52 week low of Rs. 315.20 on 23-Mar-2020.

Last one week high and low of the scrip stood at Rs. 528.45 and Rs. 483.00 respectively. The current market cap of the company is Rs. 119234.95 crore.

The promoters holding in the company stood at 54.69%, while Institutions and Non-Institutions held 32.81% and 12.50% respectively.

Sun Pharmaceutical Industries is looking to expand its specialty business across different regions like Greater China and Japan after having established presence in the US market. The company's strategy of developing the specialty business as an additional growth engine has started delivering results, with a gradual ramp up in specialty revenues. The company expects this momentum to continue over the next few years, although the COVID-19 pandemic and lockdowns may throw up some uncertainties in the near-term.

Sun Pharma is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.

Sun Pharma Inds. Share Price

1795.30 -9.65 (-0.53%)
08-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.30
Dr. Reddys Lab 1267.15
Cipla 1497.45
Zydus Lifesciences 924.35
Lupin 2071.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×